The AIRCARE (AI-Augmented Robotics For CAncer Point of CaRE) is pleased to announce the publication of the second edition of its project newsletter, highlighting major achievements in the development of AI-powered diagnostic tools and robotic-assisted therapeutic systems for cancers of the upper aerodigestive tract (UADT) during its first year. It provides a detailed overview of the project’s progress, showcasing how interdisciplinary collaboration across Europe is driving innovation in clinical cancer care.
Clinical milestone: CARDINE study approved
A key highlight is the successful ethical approval of the CARDINE clinical study in Italy, Spain, and Belgium. This milestone enables the evaluation of three AI algorithms—CADe, CADx, and CASe—on retrospective videoendoscopy data, setting the stage for clinical validation and real-world application. CARDINE ethical approval
Laying the groundwork for innovation
Led by ACMIT, the consortium has finalised the product and component requirements for AIRCARE’s diagnostic and therapeutic systems, shaped through extensive consultation with clinicians and stakeholders to ensure both clinical relevance and user-centred design. Regulatory management processes have also been established, and detailed evaluation protocols are now in place to guide verification and validation in the next phases of the project.
Technical highlights
During the first 12 months of the AIRCARE project, substantial progress was made across the core technical work packages, laying the groundwork towards the clinical valuation.
Consortium activities and public engagement
The newsletter also highlights AIRCARE’s participation in international conferences, clinical workshops, and stakeholder meetings. The project has gained national media attention and continues to expand its outreach efforts to raise awareness of its mission and impact.
As AIRCARE enters its second year, the focus will shift toward clinical validation and system integration.
Upcoming science events
For more information, please visit:
